BCCNM recognizes your efforts and challenges in working in a pandemic. If you need more information or wish to speak with someone about a practice concern, please contact one of our Regulatory Practice Consultants.
Health Canada has introduced regulatory exemptions to improve pharmacological and therapeutic options for allowing patients to access controlled medications during the COVID-19 pandemic.
The Ministry of Health, the College of Pharmacists of BC, BCCNP and others are working toward a solution. In these exceptional times, prescribers are asked to ensure their patients have an unbroken supply of these medications. If it is not possible to meet with a patient face-to-face, prescribers should consider alternative means to getting duplicate prescriptions to pharmacies.
Health Canada has
provided temporary exemptions to parts of the
Controlled Drugs and Substances Act (CDSA) and its Regulations to permit pharmacists to extend prescriptions, transfer prescriptions, and for pharmacists and pharmacy employees to deliver controlled medications, and to permit prescribers to issue verbal orders for controlled medications.
The BC Centre on Substance Use has developed updated clinical guidance for prescribers and pharmacists to improve access to OAT in the context of COVID-19.
Visit their website to access these resources.
The BC Centre on Substance Use (BCCSU) has put together guidance for OAT prescribers during the COVID-19 pandemic.